Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-16

Clinical Trial Update: Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer [NA]

View source ↗

Summary

A clinical trial evaluating diffusion-weighted MRI for individualized radiation therapy planning in non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer | NA | Status: WITHDRAWN